Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/1/16 → 01/24/18 |
Funding
- Covance: $9,606.25
AstraZeneca: A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination with Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients with Advanced ....
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research